Browsing: Will

Illinois’ new Companion Animal Custody Equity Act takes effect Jan. 1, 2027, expanding how courts may resolve pet custody disputes

The pharmaceutical powerhouse Eli Lilly announced Monday that it will give access to the experimental obesity drug, ‌retatrutide, to a limited number of eligible patients before the drug is FDA approved

A new research institute will transform understanding of obesity, its links to serious illness and help develop better approaches to prevention and treatment

 Indiana Governor Mike Braun today directed the Indiana Family and Social Services Administration (FSSA) to participate in the Center for Medicare and Medicaid Innovation’s BALANCE demonstration, expanding access to select GLP-1 medications for eligible Indiana Medicaid members living with obesity. Under the terms of the demonstration, pharmaceutical manufacturers, including Indiana’s own Eli Lilly and Company…

The Illinois Prisoner Review Board on Friday denied a bid for medical release from Sean Grayson, the former Sangamon County sheriff’s deputy convicted of second-degree murder in the 2024 killing of Sonya Massey. 

The Trump administration could be seeking emergency room medical records from hospitals across the country — are Philadelphia hospitals included?

Emergency rooms across the U.S. are reportedly being required by the Trump administration to hand over medical records for millions of patients

The running app Runna just announced a new feature that automatically adjusts workout sessions to account for local heat and humidity. This lets people plan workouts in advance with the knowledge that the system will adapt if the temperature gets too hot for comfort. Changes typically take the form of reducing running speeds

Novo Nordisk NVO is a dominant player in the cardiometabolic space, mainly due to the encouraging uptake of its blockbuster semaglutide-based (GLP-1) drugs — Ozempic (for type II diabetes [T2D]) and Wegovy (for obesity)

In his 2023 bestseller, Determined, neuroscientist Robert Sapolsky argued that the interaction of biology and environment leaves no room for free choice. Philosopher and neuroscientist Sam Harris puts the case more bluntly: “free will is an illusion”